OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The HSF1/miR-135b-5p axis induces protective autophagy to promote oxaliplatin resistance through the MUL1/ULK1 pathway in colorectal cancer
Huiya Wang, Xia Wang, Haiyang Zhang, et al.
Oncogene (2021) Vol. 40, Iss. 28, pp. 4695-4708
Closed Access | Times Cited: 50
Huiya Wang, Xia Wang, Haiyang Zhang, et al.
Oncogene (2021) Vol. 40, Iss. 28, pp. 4695-4708
Closed Access | Times Cited: 50
Showing 1-25 of 50 citing articles:
Autophagy and beyond: Unraveling the complexity of UNC-51-like kinase 1 (ULK1) from biological functions to therapeutic implications
Ling Zou, Minru Liao, Yongqi Zhen, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 10, pp. 3743-3782
Open Access | Times Cited: 48
Ling Zou, Minru Liao, Yongqi Zhen, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 10, pp. 3743-3782
Open Access | Times Cited: 48
Autophagy inhibitors for cancer therapy: Small molecules and nanomedicines
Jianli Chen, Xuan Wu, Dan Yin, et al.
Pharmacology & Therapeutics (2023) Vol. 249, pp. 108485-108485
Open Access | Times Cited: 40
Jianli Chen, Xuan Wu, Dan Yin, et al.
Pharmacology & Therapeutics (2023) Vol. 249, pp. 108485-108485
Open Access | Times Cited: 40
Targeting HSF1 for cancer treatment: mechanisms and inhibitor development
Yeh Chin, Khanisyah E. Gumilar, Li X, et al.
Theranostics (2023) Vol. 13, Iss. 7, pp. 2281-2300
Open Access | Times Cited: 30
Yeh Chin, Khanisyah E. Gumilar, Li X, et al.
Theranostics (2023) Vol. 13, Iss. 7, pp. 2281-2300
Open Access | Times Cited: 30
METTL14-dependent maturation of pri-miR-17 regulates mitochondrial homeostasis and induces chemoresistance in colorectal cancer
Kangyue Sun, Lu Chen, Yiwen Li, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 29
Kangyue Sun, Lu Chen, Yiwen Li, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 29
Crosstalk between non-coding RNAs and programmed cell death in colorectal cancer: implications for targeted therapy
Seyed Reza Taha, Mehdi Karimi, Bahar Mahdavi, et al.
Epigenetics & Chromatin (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Seyed Reza Taha, Mehdi Karimi, Bahar Mahdavi, et al.
Epigenetics & Chromatin (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Construction of size-transformable supramolecular nano-platform against drug-resistant colorectal cancer caused by Fusobacterium nucleatum
Xiangjie Yan, Feihe Ma, Qixian Chen, et al.
Chemical Engineering Journal (2022) Vol. 450, pp. 137605-137605
Closed Access | Times Cited: 28
Xiangjie Yan, Feihe Ma, Qixian Chen, et al.
Chemical Engineering Journal (2022) Vol. 450, pp. 137605-137605
Closed Access | Times Cited: 28
MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine
Elisa Martino, Nunzia D’Onofrio, Camilla Anastasio, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 371-384
Open Access | Times Cited: 16
Elisa Martino, Nunzia D’Onofrio, Camilla Anastasio, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 371-384
Open Access | Times Cited: 16
miR-135b Aggravates Fusobacterium nucleatum-Induced Cisplatin Resistance in Colorectal Cancer by Targeting KLF13
Zeng Wei, Pan Jia, Guannan Ye
The Journal of Microbiology (2024) Vol. 62, Iss. 2, pp. 63-73
Closed Access | Times Cited: 6
Zeng Wei, Pan Jia, Guannan Ye
The Journal of Microbiology (2024) Vol. 62, Iss. 2, pp. 63-73
Closed Access | Times Cited: 6
miR-424-5p Promotes Proliferation, Migration and Invasion of Colorectal Cancer Cells via the Targeting TXNIP/Hippo Axi
Feng Zhang, Kaili Zhu, Rui Chen, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 261-271
Open Access
Feng Zhang, Kaili Zhu, Rui Chen, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 261-271
Open Access
Effects of microplastics on chemo-resistance and tumorigenesis of colorectal cancer
Wen Pan, Yueting Han, Mingqing Zhang, et al.
APOPTOSIS (2025)
Closed Access
Wen Pan, Yueting Han, Mingqing Zhang, et al.
APOPTOSIS (2025)
Closed Access
miR-135b: A Key Role in Cancer Biology and Therapeutic Targets
Yingchun Shao, Shuangshuang Zhang, Yuxin Pan, et al.
Non-coding RNA Research (2025) Vol. 12, pp. 67-80
Open Access
Yingchun Shao, Shuangshuang Zhang, Yuxin Pan, et al.
Non-coding RNA Research (2025) Vol. 12, pp. 67-80
Open Access
Mesenchymal Stem Cell-Derived Exosomes in Cancer Resistance Against Therapeutics
Vignesh Balaji E, Keerthilatha M. Pai, K. Sreedhara Ranganath Pai
Cancers (2025) Vol. 17, Iss. 5, pp. 831-831
Open Access
Vignesh Balaji E, Keerthilatha M. Pai, K. Sreedhara Ranganath Pai
Cancers (2025) Vol. 17, Iss. 5, pp. 831-831
Open Access
TBK1 is a signaling hub in coordinating stress-adaptive mechanisms in head and neck cancer progression
Hyo Jeong Kim, Haeng‐Jun Kim, Sunyong Kim, et al.
Autophagy (2025)
Open Access
Hyo Jeong Kim, Haeng‐Jun Kim, Sunyong Kim, et al.
Autophagy (2025)
Open Access
miR‐135b‐5p/PDE3B Axis Regulates Gemcitabine Resistance in Pancreatic Cancer Through Epithelial‐Mesenchymal Transition
Yuxuan Fu, Liangsheng Chen, Ning Lv, et al.
Molecular Carcinogenesis (2025)
Closed Access
Yuxuan Fu, Liangsheng Chen, Ning Lv, et al.
Molecular Carcinogenesis (2025)
Closed Access
Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer
Gang Wang, Junjie Wang, Zhimin Zhu, et al.
Science Progress (2023) Vol. 106, Iss. 1
Open Access | Times Cited: 12
Gang Wang, Junjie Wang, Zhimin Zhu, et al.
Science Progress (2023) Vol. 106, Iss. 1
Open Access | Times Cited: 12
Colon-targeted S100A8/A9-specific peptide systems ameliorate colitis and colitis-associated colorectal cancer in mouse models
Euni Cho, Seok‐Jun Mun, Hyo Keun Kim, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 3, pp. 581-593
Closed Access | Times Cited: 11
Euni Cho, Seok‐Jun Mun, Hyo Keun Kim, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 3, pp. 581-593
Closed Access | Times Cited: 11
Novel mechanism of drug resistance triggered by tumor-associated macrophages through Heat Shock Factor-1 activation
Alina D. Nikotina, Snezhana A. Vladimirova, Nadezhda E. Kokoreva, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 2
Open Access | Times Cited: 4
Alina D. Nikotina, Snezhana A. Vladimirova, Nadezhda E. Kokoreva, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 2
Open Access | Times Cited: 4
Engineering lauric acid-based nanodrug delivery systems for restoring chemosensitivity and improving biocompatibility of 5-FU and OxPt against Fn-associated colorectal tumor
Meihui Su, Xin Wen, Yunjian Yu, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 16, pp. 3947-3958
Closed Access | Times Cited: 4
Meihui Su, Xin Wen, Yunjian Yu, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 16, pp. 3947-3958
Closed Access | Times Cited: 4
HSF1 at the crossroads of chemoresistance: from current insights to future horizons in cell death mechanisms
Shruti Ghai, Rejina Shrestha, Kuo‐Hui Su
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Shruti Ghai, Rejina Shrestha, Kuo‐Hui Su
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
Dezhi Yan, Qingliu He, Chunjian Wang, et al.
Wiley Interdisciplinary Reviews - RNA (2025) Vol. 16, Iss. 2
Closed Access
Mitochondrial E3 ubiquitin ligase 1 (MUL1 ) as a novel therapeutic target for diseases associated with mitochondrial dysfunction
Ximena Calle, Valeria Garrido‐Moreno, Erik Lopez‐Gallardo, et al.
IUBMB Life (2022) Vol. 74, Iss. 9, pp. 850-865
Closed Access | Times Cited: 18
Ximena Calle, Valeria Garrido‐Moreno, Erik Lopez‐Gallardo, et al.
IUBMB Life (2022) Vol. 74, Iss. 9, pp. 850-865
Closed Access | Times Cited: 18
Epigenetic regulation of autophagy by non-coding RNAs in gastrointestinal tumors: Biological functions and therapeutic perspectives
Mohammad Arad Zandieh, Melika Heydari Farahani, Romina Rajabi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106582-106582
Open Access | Times Cited: 16
Mohammad Arad Zandieh, Melika Heydari Farahani, Romina Rajabi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106582-106582
Open Access | Times Cited: 16
miR-135b: An emerging player in cardio-cerebrovascular diseases
Yingchun Shao, Jiazhen Xu, Wujun Chen, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 10, pp. 100997-100997
Open Access | Times Cited: 3
Yingchun Shao, Jiazhen Xu, Wujun Chen, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 10, pp. 100997-100997
Open Access | Times Cited: 3
Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential
Zheng-Dong Luo, Yifeng Wang, Yu-Xiao Zhao, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 1, pp. 1-18
Open Access | Times Cited: 8
Zheng-Dong Luo, Yifeng Wang, Yu-Xiao Zhao, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 1, pp. 1-18
Open Access | Times Cited: 8
Targeting autophagy in colorectal cancer: An update on pharmacological small-molecule compounds
Zixiang Li, Wen Si, Wenke Jin, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 8, pp. 2373-2385
Closed Access | Times Cited: 13
Zixiang Li, Wen Si, Wenke Jin, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 8, pp. 2373-2385
Closed Access | Times Cited: 13
